These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8850383)

  • 61. Safety, tolerability, and efficacy of simvastatin and fenofibrate--a multicenter study. Simvastatin-Fenofibrate Study Group.
    Ziegler O; Drouin P
    Cardiology; 1990; 77 Suppl 4():50-7. PubMed ID: 2073672
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Simvastatin and cholestyramine in the long-term treatment of hypercholesterolaemia.
    Ytre-Arne K; Nordøy A
    J Intern Med; 1989 Nov; 226(5):285-90. PubMed ID: 2681508
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
    Marnini P; Colombo F; Cattaneo R; Geroli L; Venco A
    Int J Clin Pharmacol Res; 1992; 12(2):65-70. PubMed ID: 1428300
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prediction of the therapeutic response to simvastatin by pretreatment lipid concentrations in 2082 subjects.
    Miserez AR; Rossi FA; Keller U
    Eur J Clin Pharmacol; 1994; 46(2):107-14. PubMed ID: 8039527
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of the lipid-lowering effect of simvastatin and tiadenol].
    Serra T; Gavelli MS; Vitaliano E; Santini G; Catalano A; Rossi FG; Tozzi J; Caridis R; Guarini G
    Clin Ter; 1990 Mar; 132(5):307-13. PubMed ID: 2139833
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Hypercholesterolemia: therapeutic approach].
    Alessandri C; Peverini F
    Clin Ter; 1991 Jun; 137(6):373-97. PubMed ID: 1832610
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Is fat restriction needed with HMGCoA reductase inhibitor treatment?
    Clifton PM; Wight MB; Nestel PJ
    Atherosclerosis; 1992 Mar; 93(1-2):59-70. PubMed ID: 1596304
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of simvastatin for lowering cholesterol in non-insulin dependent diabetic patients with hypercholesterolemia.
    Daubresse JC; Machowski R; Pulinx E
    Acta Clin Belg; 1994; 49(2):68-75. PubMed ID: 8067175
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Simvastatin increases plasma NO2- and NO3- levels in patients with hypercholesterolemia.
    Nakashima Y; Toyokawa Y; Tanaka S; Yamashita K; Yashiro A; Tasaki H; Kuroiwa A
    Atherosclerosis; 1996 Nov; 127(1):43-7. PubMed ID: 9006803
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
    Mol MJ; Stuyt PM; Stalenhoef AF
    Ned Tijdschr Geneeskd; 1989 Feb; 133(7):362-6. PubMed ID: 2927555
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels.
    Alaupovic P; Heinonen T; Shurzinske L; Black DM
    Atherosclerosis; 1997 Aug; 133(1):123-33. PubMed ID: 9258416
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Simvastatin in non-insulin-dependent diabetic patients with hypercholesterolaemia.
    Steyn K; Weich HF; Bonnici F; Kotze TJ; Stander I; Vermaak WJ; Lourens W; van Lathem J; Omar MA; Fourie J
    S Afr Med J; 1992 Dec; 82(6):402-6. PubMed ID: 1465688
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical investigation on the hypolipidemic effect of simvastatin in primary hypercholesterolemia.
    Saba P; Galeone F; Giuntoli F; Spagnolo G; Brunelleschi G; Lamanna F; Angelé B
    Clin Ter; 1992 Jan; 140(1 Pt 2):3-9. PubMed ID: 1559319
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB; Cushman W; Applegate WB; Heimberg M
    Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
    [No Abstract]   [Full Text] [Related]  

  • 76. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
    Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
    J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
    Bruckert E; De Gennes JL; Malbecq W; Baigts F
    Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Simvastatin (MK 733): an effective treatment for hypercholesterolemia.
    Lintott CJ; Scott RS; Nye ER; Robertson MC; Sutherland WH
    Aust N Z J Med; 1989 Aug; 19(4):317-20. PubMed ID: 2675812
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of simvastatin on the number and composition of apoproteinB-containing lipoproteins in hypercholesterolemia: analysis of apoproteinB in each lipoprotein fraction by highly sensitive latex method.
    Ikeda Ryomoto K; Suzuki M; Tsushima M; Yamamoto A; Harano Y
    Endocr J; 1996 Oct; 43(5):469-75. PubMed ID: 8980885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.